CD70 and cancer: CD70 chimeric antigen receptor natural killer cells (CD70-CAR-NK), engineered with IL-15, hnCD16, and CD70 knockout, target tumor cells and cancer-associated fibroblasts with minimal off-tumor effects, exhibiting potent cytotoxicity and prolonged persistence (48).